60 related articles for article (PubMed ID: 8377287)
1. [Lymphocyte subpopulations in maintenance hemodialysis patients receiving recombinant human erythropoietin].
Kaneko Y; Motomiya Y; Arai K; Kagebayashi Y; Okada H; Sasaki K; Yoneda T; Yoshida K; Ozono S; Hirao Y
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):743-9. PubMed ID: 8377287
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human erythropoietin administration on immunological indices in patients undergoing chronic hemodialysis.
Yorioka N; Hamaguchi N; Takasugi N; Shigemoto K; Harada S; Fujiwara K; Ishida A; Maeda T; Kawai A; Yamakido M
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):981-8. PubMed ID: 8255010
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients.
Trzonkowski P; Myśliwska J; Debska-Slizień A; Bryl E; Rachoń D; Myśliwski A; Rutkowski B
Nephrol Dial Transplant; 2002 Jun; 17(6):1070-80. PubMed ID: 12032199
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subset counts in continuous ambulatory peritoneal dialysis patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors.
Grzegorzewska AE; Leander M
Adv Perit Dial; 2002; 18():6-11. PubMed ID: 12402577
[TBL] [Abstract][Full Text] [Related]
5. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
[TBL] [Abstract][Full Text] [Related]
6. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin].
Tanabe R
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1159-68. PubMed ID: 7815748
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte subsets and NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant human erythropoietin (rHu-EPO) treatment.
Baj Z; Pokoca L; Majewska E; Luciak M; Tchórzewski H
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):201-6. PubMed ID: 1300984
[TBL] [Abstract][Full Text] [Related]
8. Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients.
Trzonkowski P; Debska-Slizien A; Szmit E; Myśliwska J; Szymańska K; Hak Ł; Myśliwski A; Rutkowski B
Nephrol Dial Transplant; 2005 Feb; 20(2):367-76. PubMed ID: 15585513
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure.
Pereira R; Costa E; Gonçalves M; Miranda V; do Sameiro Faria M; Quintanilha A; Belo L; Lima M; Santos-Silva A
Hemodial Int; 2010 Jul; 14(3):295-301. PubMed ID: 20649681
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects on lymphocytotoxic antibodies and immune reactivity in hemodialysis patients treated with recombinant human erythropoietin.
Bárány P; Fehrman I; Godoy C
Clin Nephrol; 1992 Feb; 37(2):90-6. PubMed ID: 1551255
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
Raja R; Bloom E; Johnson R
Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group).
Muirhead N; Laupacis A; Wong C
Nephrol Dial Transplant; 1992; 7(8):811-6. PubMed ID: 1325613
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
de Sousa FT; Prata MM; Barbas JV; dos Santos JP
Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.
Mazzoccoli G; Balzanelli M; Giuliani A; De Cata A; La Viola M; Carella AM; Bianco G; Tarquini R
In Vivo; 1999; 13(3):205-9. PubMed ID: 10459492
[TBL] [Abstract][Full Text] [Related]
16. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
Raja R; Bloom E; Johnson R; Goldstein M
Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
[TBL] [Abstract][Full Text] [Related]
17. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility?
Grooteman MP; Nube MJ; van Limbeek J; Schoorl M; van Houte AJ
Nephrol Dial Transplant; 1996 Jun; 11(6):1073-8. PubMed ID: 8671971
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Leander M
Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human erythropoietin (rHuEPO) on nutritional status of hemodialysis patients: investigation of direct anabolic effects of rHuEPO.
Usuba T; Kuno T; Higuchi T; Kikuchi F; Nagura Y; Kanmatsuse K; Takahashi S
Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1288-95. PubMed ID: 7853762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
